600216 logo

Zhejiang Medicine Co., Ltd. Stock Price

SHSE:600216 Community·CN¥16.8b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 1 Fair Values set on narratives written by author

600216 Share Price Performance

CN¥17.76
3.79 (27.13%)
CN¥17.76
3.79 (27.13%)
Price CN¥17.76

600216 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet, undervalued and pays a dividend.

2 Risks
3 Rewards

Zhejiang Medicine Co., Ltd. Key Details

CN¥9.0b

Revenue

CN¥5.5b

Cost of Revenue

CN¥3.4b

Gross Profit

CN¥2.2b

Other Expenses

CN¥1.2b

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
Apr 24, 2026
1.31
38.47%
13.89%
8.5%
View Full Analysis

About 600216

Founded
1997
Employees
5815
CEO
Hongwei Wang
WebsiteView website
www.zmc.top

Zhejiang Medicine Co., Ltd. manufactures and sells life nutrition and medical products in China and internationally. The company offers synthetic vitamin E, natural vitamin E, ß-carotene, cantharidin, vancomycin hydrochloride, and teicoplanin. It also provides fat-soluble vitamins, retinoids, quinolone antibiotics, anti-resistance antibiotics, and other products, as well as animal nutrition products. In addition, the company offers injectable levofloxacin lactate, injectable vancomycin hydrochloride injections, and injectable teicoplanin products. The company was incorporated in 1997 and is based in Shaoxing, China.

Recent 600216 News & Updates

Recent updates

No updates